Results 151 to 160 of about 332,049 (298)
ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers +7 more
wiley +1 more source
A Systematic Comparison of Alpha‐Synuclein Seed Amplification Assays for Increasing Reproducibility
ABSTRACT Seed amplification assays (SAAs) enable ultrasensitive detection of misfolded α‐synuclein across biofluids and tissues. Yet, heterogeneity in protocols limits cross‐study comparability and clinical translation. Here, we review α‐synuclein SAA methods and their performance across various biological matrices.
Manuela Amaral‐do‐Nascimento +3 more
wiley +1 more source
Public participation and willingness to cooperate in common-pool resource management: a field experiment with fishing communities in Brazil [PDF]
The primary evidence about the factors determining successful self-governance of common-pool resources (CPR) has come from case studies. More recently, this observational evidence has been complemented by insights from economic experiments.
Cavalcanti, Carina +2 more
core
Do we have (in)compatibilist phenomenology of deliberation?: a survey. [PDF]
Honma S, Inarimori K, Miyazono K.
europepmc +1 more source
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
Deliberation as a condition for meaningful participation in health and healthcare research. [PDF]
Marinus JD.
europepmc +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Community perspectives on health AI: hopes, concerns and implications for health systems and trustworthy AI. [PDF]
Ryan KA +10 more
europepmc +1 more source

